Tributary Capital Management LLC grew its position in Simulations Plus, Inc. (NASDAQ:SLP – Free Report) by 21.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 396,093 shares of the technology company’s stock after acquiring an additional 70,526 shares during the quarter. Tributary Capital Management LLC owned about 1.97% of Simulations Plus worth $11,047,000 as of its most recent SEC filing.
A number of other institutional investors have also recently made changes to their positions in SLP. Envestnet Asset Management Inc. lifted its holdings in Simulations Plus by 1.5% in the 2nd quarter. Envestnet Asset Management Inc. now owns 54,813 shares of the technology company’s stock valued at $2,665,000 after purchasing an additional 784 shares in the last quarter. Dimensional Fund Advisors LP lifted its stake in shares of Simulations Plus by 10.1% in the second quarter. Dimensional Fund Advisors LP now owns 414,005 shares of the technology company’s stock worth $20,128,000 after buying an additional 37,992 shares in the last quarter. Public Sector Pension Investment Board grew its stake in Simulations Plus by 6.4% during the 2nd quarter. Public Sector Pension Investment Board now owns 35,227 shares of the technology company’s stock valued at $1,713,000 after acquiring an additional 2,122 shares in the last quarter. Deerfield Management Company L.P. Series C purchased a new stake in Simulations Plus during the 2nd quarter valued at about $811,000. Finally, The Manufacturers Life Insurance Company raised its holdings in Simulations Plus by 7.7% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 6,391 shares of the technology company’s stock valued at $311,000 after acquiring an additional 456 shares during the last quarter. 78.08% of the stock is owned by institutional investors and hedge funds.
Insider Buying and Selling
In related news, Director Walter S. Woltosz sold 20,000 shares of the firm’s stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $31.76, for a total value of $635,200.00. Following the sale, the director now owns 3,442,584 shares of the company’s stock, valued at $109,336,467.84. This trade represents a 0.58 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 19.40% of the stock is currently owned by insiders.
Analyst Ratings Changes
Read Our Latest Report on Simulations Plus
Simulations Plus Price Performance
Shares of NASDAQ:SLP opened at $33.78 on Friday. The firm’s 50-day moving average is $29.95 and its two-hundred day moving average is $32.89. Simulations Plus, Inc. has a 1 year low of $24.00 and a 1 year high of $51.22. The firm has a market capitalization of $678.64 million, a PE ratio of 84.45 and a beta of 0.80.
Simulations Plus (NASDAQ:SLP – Get Free Report) last released its earnings results on Wednesday, October 23rd. The technology company reported $0.06 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.04 by $0.02. The company had revenue of $18.70 million for the quarter, compared to analyst estimates of $19.73 million. Simulations Plus had a net margin of 10.97% and a return on equity of 6.84%. The firm’s quarterly revenue was up 19.9% on a year-over-year basis. During the same period in the prior year, the business earned $0.18 EPS. Analysts expect that Simulations Plus, Inc. will post 1.09 EPS for the current fiscal year.
Simulations Plus Company Profile
Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.
See Also
- Five stocks we like better than Simulations Plus
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Bloom Energy: Powering the Future With Decentralized Energy
- What Do S&P 500 Stocks Tell Investors About the Market?
- Dividend Powerhouses: Blue-Chip Stocks Built for the Long Haul
- How to Short a Stock in 5 Easy StepsÂ
- Why Traders Are Buying the Dip on Johnson & Johnson Stock
Want to see what other hedge funds are holding SLP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Simulations Plus, Inc. (NASDAQ:SLP – Free Report).
Receive News & Ratings for Simulations Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus and related companies with MarketBeat.com's FREE daily email newsletter.